Last update:
Vaccination news
Diseases, Conditions, Syndromes
Vaccine alliance secures deal for 500,000 mpox jabs for Africa
The Gavi vaccine alliance announced Wednesday a deal with Danish drugmaker Bavarian Nordic to secure 500,000 jabs against mpox for use in African countries facing an epidemic of the virus.
17 hours ago
0
0
Immunology
Critical immune factor for host defense against MRSA offers potential explanation for unsuccessful vaccine strategies
Staphylococcus aureus, mostly known from its antibiotic-resistant variant methicillin-resistant Staphylococcus aureus (MRSA), is among the leading causes of both community- and hospital-acquired infections. According to the ...
Sep 17, 2024
0
11
Expert advice on preparing for the fall COVID, flu season
People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says.
Sep 16, 2024
0
1
This city is hailed as a vaccination success. Can it be sustained?
On his first day of school at Newcomer Academy, Maikel Tejeda was whisked to the school library. The 7th grader didn't know why.
Sep 16, 2024
0
0
WHO grants first mpox vaccine approval to ramp up response to disease in Africa
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa.
Sep 13, 2024
0
0
Promising Lassa fever vaccine is headed to phase I clinical trial
Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Geneva Foundation, have ...
Sep 12, 2024
0
27
National survey shows hesitancy about vaccines this fall, with 37% of respondents believing they don't need vaccination
With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this ...
Sep 12, 2024
0
0
COVID-19, flu and RSV shots: Q&A with a pharmacist
Vaccinations have become a traditional part of flu season with the influenza vaccine revised most years to protect from new strains of the illness.
Sep 12, 2024
0
1
Danish mpox vaccine maker to supply additional 2 mn doses in 2024
Danish drugmaker Bavarian Nordic, on Thursday pledged to supply a further two million doses of its mpox vaccine by the end of the year.
Sep 12, 2024
0
0
A new type of RNA could enhance vaccines and cancer treatments
It all started in the lab. Two Boston University doctoral students, Joshua McGee and Jack Kirsch, were creating and testing different types of RNA—strands of ribonucleic acid, built from chains of chemical compounds called ...
Sep 11, 2024
0
19
One dose of smallpox vaccine found to be moderately effective in preventing mpox infection
One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ .
Sep 11, 2024
0
0
Q&A: Is now the time for a new COVID-19 shot?
The COVID-19 summer surge was a surprise, but are we safe now that the numbers are trending downward?
Sep 11, 2024
0
0
New COVID vaccines may be coming to Australia—here's what to know about the JN.1 shots
COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have saved more than 1.4 million lives in the World Health Organization's (WHO) European region alone ...
Sep 10, 2024
0
0
DR Congo gets 50,000 mpox vaccine delivery from US
Democratic Republic of Congo received on Tuesday 50,000 more vaccine doses from the United States to fight the country's mpox epidemic, adding to some 200,000 donated by the European Union.
Sep 10, 2024
0
0
Cross-disciplinary research makes strides in hepatitis C vaccine development
Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year.
Sep 9, 2024
0
25
Machine learning may lead to better flu vaccines
A team led by scientists at UGA's Odum School of Ecology has developed an algorithm that can accurately predict how a seasonal flu virus is expected to evolve. Such information may allow seasonal flu vaccines to be updated ...
Sep 9, 2024
0
18
New study highlights importance of targeting unchanging parts of COVID-19 virus
For the past three years, Corewell Health researchers have been studying the genetic code of the virus that causes COVID-19 to better understand how it is changing and how to avoid another pandemic. Much of the world's focus ...
Sep 9, 2024
0
0
Study highlights key role of COVID-19 boosters in preventing serious illness
New research analyzing health data for more than five million Kiwi residents shows COVID-19 vaccinations have been most effective at preventing infections and hospital admissions in the first month after they're administered. ...
Sep 9, 2024
0
0
RSV vaccination in older adults with health conditions is cost-effective, modeling study finds
Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modeling study in the Canadian Medical Association ...
Sep 9, 2024
0
2
Video: How testing has kept up with new COVID-19 variants
While COVID-19 continues to evolve, there is some good news when it comes to detecting the virus.
Sep 9, 2024
0
0
Health agencies scramble to prepare for new mpox strain
State and federal health agencies are gearing up to respond to a new strain of mpox—the virus formerly known as monkeypox—if the new strain spreads to the United States.
Sep 6, 2024
0
0
Artificial lymphoid organs could help predict efficacy of booster vaccines
Researchers at the Institut Pasteur in France have developed artificial "lymphoid organ-chips" that recreate much of the human immune system's response to booster vaccines. The technology, described in an article published ...
Sep 6, 2024
0
0
Study shows that vaccination against RSV lowers the risk of hospitalization in people over 60
A team of doctors and medical researchers from Vanderbilt University Medical Center and the Centers for Disease Control and Prevention has found that vaccinating people 60 years and older against the respiratory syncytial ...
Vaccination skepticism and esoteric attitudes are linked, study finds
Esoteric attitudes—especially with regard to complementary and alternative medicine—have an influence on the willingness to be vaccinated. Dr. Sebastian Jäckle and Dr. James K. Timmis, both from the Department of Political ...
Sep 5, 2024
0
1
New RSV vaccine for older adults can result in individual and societal cost savings, benefits
Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Sep 5, 2024
0
0
